What Is Bone Marrow Fat and Why Does It Matter?

Bone marrow fat is a specialized fat tissue that fills the cavities inside your bones, distinct from the fat under your skin or around your organs. By adulthood, it accounts for roughly 70 percent of bone marrow volume and about 10 percent of total body fat mass, making it one of the largest fat depots most people have never heard of. Far from being inert filler, marrow fat actively influences bone strength, blood cell production, metabolism, and even how cancers behave once they reach the skeleton. Researchers now treat it as a unique organ in its own right, and understanding it is reshaping how we think about osteoporosis, metabolic disease, and aging.

A Fat Depot Unlike Any Other

Your body has several kinds of fat. White fat stores calories. Brown fat burns them for heat. Bone marrow fat cells share a common ancestor with both but behave differently from either. They arise from the same pool of stem cells that produce bone-building cells, and that shared origin is central to why marrow fat matters so much for skeletal health. Marrow fat cells are anatomically and functionally separate from brown, beige, and classic white fat, which is why researchers classify them as their own depot, commonly called marrow adipose tissue.

¹

Even physically, marrow fat cells look different. They tend to be smaller than subcutaneous or visceral fat cells, with diameters ranging from about 40 to 65 micrometers in humans depending on the bone site, the person’s age, and how much fat has accumulated locally.

²

Two Subtypes With Different Jobs

Not all bone marrow fat is the same. Researchers recognize two subtypes: constitutive marrow adipocytes, found mainly in the distal skeleton (think your hands, feet, and the tail end of long bones), and regulated marrow adipocytes, which populate areas closer to the body’s core, like the spine and the upper portions of the thighbone. These two populations differ in size, fatty acid makeup, and how readily they appear or disappear in response to metabolic signals.

³

The distinction matters because the two subtypes interact with bone differently. In mouse studies, removing regulated marrow fat from the upper tibia did not consistently change bone structure. But reducing constitutive marrow fat in the tail vertebrae and distal tibia led to meaningful gains in both the spongy interior bone and the hard outer shell.

⁴

That finding suggests constitutive fat may be the more active suppressor of local bone formation, though the picture is still being filled in. The takeaway is that lumping all marrow fat together misses important biology.

The Tug-of-War Between Fat and Bone

Here is the core reason bone marrow fat draws so much research attention: the stem cells that become marrow fat cells are the very same stem cells that become bone-forming cells. These mesenchymal stem cells sit at a crossroads, and conditions that push them toward becoming fat cells tend to pull them away from becoming bone cells, and vice versa. Factors that promote fat formation inhibit bone formation, while signals that drive bone building suppress fat accumulation.

⁵

This inverse relationship helps explain a pattern seen consistently in aging: as people grow older, bone marrow fills with more fat and bones become thinner and weaker. In animal studies, aging is accompanied by a rise in fat-related gene activity in the marrow and a roughly three-fold increase in the expression of a molecule called RANKL, which promotes bone breakdown.

⁶

Regions of marrow packed with fat show fewer bone-building cells, fewer bone-maintaining cells embedded in the bone matrix, and more bone-dissolving cells, all of which add up to weaker bone in those areas.

⁷

The Anorexia Paradox

If marrow fat simply tracked overall body fat, people who are severely underweight would have less of it. The opposite is true in anorexia nervosa. Despite extreme depletion of subcutaneous and visceral fat, people with anorexia show paradoxically elevated marrow fat levels.

⁸

Women with anorexia have been found to carry more marrow fat in the lumbar spine and femur than healthy controls, and this excess marrow fat correlates inversely with bone density — more marrow fat, weaker bones.

⁹

This paradox was one of the early clues that marrow fat is regulated independently from other fat depots. It also underscores that the skeletal damage in anorexia is not just about calcium or vitamin D deficiency; something about caloric restriction or the hormonal changes it triggers actively redirects stem cells toward fat at the expense of bone, even when the rest of the body is starving for energy.

It Is Not Just How Much Fat, but What Kind

The chemical makeup of marrow fat turns out to matter as much as the quantity. Marrow lipids are a mixture of saturated and unsaturated fatty acids, and these have opposite relationships with bone strength. In a study of older adults, higher saturated lipid content in vertebral marrow was associated with substantially lower bone density and compressive strength at the spine, hip, and femoral neck. Higher unsaturated lipid content, on the other hand, was linked to greater bone density and strength at the same sites.

¹⁰

Imaging studies that look at the ratio of saturated to unsaturated fat in marrow, sometimes called the unsaturation index, have confirmed that sites with a higher proportion of unsaturated fatty acids tend to have healthier bone.

¹¹

This opens an intriguing question: could interventions that shift the fatty acid profile of marrow fat, whether through diet, exercise, or medication, protect bone independently of changing the total amount of marrow fat? The research is still early, but the compositional angle adds a layer of nuance that simple fat-fraction measurements miss.

Exercise Shrinks Marrow Fat

Physical activity is one of the most reliable ways to reduce marrow fat, at least in the studies done so far. In obese mice given daily running exercise, marrow fat measured by advanced imaging dropped by roughly 23 percent in lean animals and 48 percent in obese ones. Fat cell size shrank by a third or more, and in the obese group, the number of marrow fat cells fell by over half. The mechanism appears to involve increased burning of stored lipids within marrow fat cells themselves.

¹²

The picture in humans is catching up. A trial in children with overweight or obesity found that an exercise program reduced lumbar spine marrow fat fraction, and about 40 percent of that reduction was explained by concurrent decreases in liver fat, suggesting the two depots are metabolically linked.

¹³

Exercise-induced bone formation also correlates with the suppression of marrow fat, which fits neatly with the stem-cell tug-of-war: mechanical loading from exercise may push those shared precursor cells toward making bone instead of fat.

¹⁴

Hormones and Medications That Shift the Balance

Estrogen is a powerful regulator of marrow fat. In a study of postmenopausal women with osteoporosis, those on placebo saw marrow fat volume and fat cell numbers climb by about 20 percent over a year. Women on estrogen therapy not only avoided that increase but actually saw marrow fat volume decline by around 24 percent, and their fat cell size held steady rather than growing.

¹⁵

The sharp drop in estrogen at menopause likely contributes to the surge in marrow fat that accompanies postmenopausal bone loss.

On the flip side, a class of diabetes medications called thiazolidinediones actively promotes marrow fat formation at the expense of bone. These drugs work by activating a receptor that steers stem cells toward becoming fat cells, and large trials have confirmed they increase fracture risk, particularly in women.

¹⁶

Meta-analyses have put the number needed to harm somewhere between 99 and 172, meaning for every 99 to 172 women treated, one additional fracture occurs that would not have happened otherwise.

¹⁷

If you take one of these medications and have risk factors for osteoporosis, this bone-marrow mechanism is worth discussing with your doctor.

Diabetes and an Uncertain Connection

Given that thiazolidinediones boost marrow fat, you might expect diabetes itself to cause higher marrow fat levels. Animal studies strongly support this: diabetic rodents consistently show elevated marrow fat. In humans, though, the picture is less clear. Some studies report that marrow fat correlates with blood sugar control, and there may be distinct differences in the types of lipids present in diabetic marrow, but overall the human data show smaller and less certain differences than the animal work would predict.

¹⁸

This gap between animal and human findings is a recurring theme in marrow fat research. Rodent skeletons are small, turnover is fast, and diets are easily controlled, so effects show up more dramatically. Translating those findings to humans, where marrow fat varies with age, sex, activity level, medications, and genetics, remains a work in progress.

Blood Cell Production and the Marrow Niche

Bone marrow is where blood cells are made, and fat cells inside the marrow influence that process. Marrow fat cells sit in direct contact with the stem cells that generate red blood cells, white blood cells, and platelets, and they secrete signaling molecules that can either support or suppress blood cell production.

¹⁹

In aging, the accumulation of marrow fat is associated with declining numbers of blood-forming stem cells and lower levels of growth factors that support them.

²⁰

Whether the fat directly causes those stem cells to decline, or both changes are downstream of something else, is an open question. But the association is strong enough that marrow fat is now considered a meaningful part of the stem-cell environment, not just space filler between blood-forming cells.

How Radiation and Chemotherapy Reshape the Marrow

Cancer treatments take a visible toll on marrow composition. During radiation therapy, the marrow fat fraction increases in a dose-dependent way, climbing roughly half a percentage point per unit of radiation dose delivered. More telling, the increase in fat fraction correlates with dropping white blood cell counts, linking the compositional change to measurable loss of blood-forming capacity.

²¹

Chemotherapy has a similar but more spatially uniform effect: marrow fat rises throughout the skeleton rather than concentrating in the treated area. In gynecologic cancer patients undergoing combined treatment, both lumbar and femoral marrow showed significant increases in fat fraction, with radiation-induced changes highest near the treatment field and chemotherapy-induced changes more evenly spread.

²²

The underlying mechanism is familiar: both treatments damage or kill the stem cells that would otherwise become bone-forming cells, tipping the remaining population toward fat production. The result is a fattier marrow cavity, reduced bone mass, and increased fracture risk that can persist long after treatment ends.

²³

Measuring Marrow Fat Without a Biopsy

Until the last couple of decades, measuring marrow fat required a bone biopsy, which limited research to small studies of highly motivated patients. MRI has changed that. Several MRI-based techniques now allow non-invasive quantification of both the amount and the composition of marrow fat, including water-fat imaging, proton spectroscopy, and specialized sequences that separate fat from water signals.

²⁴

One practical challenge is standardization. Fat-fraction measurements from basic vendor-supplied MRI methods tend to run up to 10 percent off compared to more specialized research sequences, though a straightforward offline correction can close most of that gap.

²⁵

This matters because if marrow fat fraction is ever going to become a routine clinical biomarker for fracture risk or metabolic health, hospitals need to be able to compare numbers across different scanners and institutions. That consistency is improving but is not yet at the level needed for clinical decision-making.

How Marrow Fat Develops From Infancy

Babies are born with marrow that is almost entirely red, full of blood-forming cells. Over childhood and adolescence, red marrow gradually converts to yellow, fatty marrow in a predictable pattern. In the femur, for example, the conversion starts in the ends of the bone, moves through the shaft, and finishes in the upper region closest to the hip.

²⁶

By the mid-twenties, fatty yellow marrow dominates the limbs, while the spine and pelvis retain more red marrow. This conversion continues at a slower pace throughout life, which is one reason marrow fat fraction keeps rising with age even in healthy people.

²⁷

Understanding this timeline is clinically useful. When radiologists read a child’s MRI, they need to know what the expected distribution of red and yellow marrow looks like at that age to avoid mistaking normal conversion for disease. In adults, a sudden shift back from fatty to red marrow in a limb can signal that the body urgently needs more blood cells, as happens in severe anemia or marrow-replacing diseases.

A Fueling Station for Metastatic Cancer

Bone is one of the most common destinations for metastatic cancer, and marrow fat cells appear to actively support tumors that arrive there. Marrow fat cells are the most abundant cell type in adult marrow, and they function as an endocrine organ, releasing fatty acids, signaling proteins, and inflammatory molecules. When tumor cells from prostate, breast, or melanoma cancers settle into the marrow, they can tap into this local energy supply.

²⁸

Preclinical work shows that marrow fat cells can be reprogrammed by tumor cells to release stored lipids, essentially acting as a fuel depot for cancer growth.

²⁹

They also secrete a cocktail of inflammatory signals that can promote tumor survival and accelerate bone destruction. The implication is that people with more marrow fat, whether due to age, obesity, or metabolic disease, may have a marrow environment that is more hospitable to metastatic cancer. This is still largely based on animal and cell-culture studies, but it has become one of the more active areas of marrow fat research.

³⁰

Marrow Fat as an Endocrine Organ

Beyond its local effects on bone and blood cells, marrow fat participates in whole-body metabolism. Marrow fat cells produce and secrete adiponectin, a hormone involved in insulin sensitivity and inflammation, at levels far exceeding what white fat produces.

³¹

During caloric restriction, when white fat shrinks but marrow fat expands, the marrow becomes a major source of circulating adiponectin. This means that the paradoxical rise in marrow fat during starvation may not be purely harmful; it could help maintain hormonal signals that the rest of the body needs. Marrow fat cells also produce leptin, another hormone that regulates energy balance.

³²

Cold Exposure and Thermal Adaptation

One question researchers have explored is whether marrow fat behaves like brown fat under cold conditions. Brown fat generates heat by burning energy, and some lab work shows that marrow-derived fat cells exposed to low temperatures in a dish ramp up heat-generating genes and shift toward a “browning” profile.

³³

In living humans, however, cold exposure does not appear to activate marrow fat the way it activates brown fat. Imaging studies show that glucose uptake by marrow fat in the spine and upper arm remains unchanged during cold exposure, suggesting marrow fat does not play a major role in thermogenesis despite its theoretical potential to do so.

³⁴

Interestingly, the fatty acid composition of marrow fat in the limbs of mammals does appear to vary with distance from the body’s warm core, with extremities containing more unsaturated fats that remain fluid at lower temperatures, much like how Arctic animals keep their leg fat liquid in the cold.

³⁵

Whether this compositional gradient matters for human skeletal health is unknown, but it is a reminder that marrow fat is more finely tuned to its local environment than a simple fat depot has any right to be.